Regulatory clarity · Vietnam
Medibase is a multilingual EN/VI/JA portal that collects reference information on medicines, supplements, foods, medical devices, and cosmetics, alongside curated guides to Vietnamese pharmaceutical regulation — registration, tendering, pricing, and pharmacovigilance.
Reference only · not a substitute for medical or legal advice.
Regulatory updates, official notices, and curated commentary
The Drug Administration of Vietnam asks manufacturers, exporters, importers and storage-service providers of drugs and drug materials to register at csdlduoc.com.vn and connect their data, while provincial Departments of Health onboard wholesalers and pharmacies. The deadline was 4 October 2026; facilities not yet registered should do so now.
Official Letter 8000/BYT-QLD circulated the draft Decree amending Decree 163/2025/ND-CP to ministries, business associations and pharmaceutical companies. The comment period ended on 2 November 2026. The Ministry of Health will now consolidate comments and finalise the draft for appraisal and submission to the Government; no issue date has been announced.
Decisions 3304, 3307, 3332 and 3410/QD-BYT withdraw the certificates of CPC1 – Ho Chi Minh City Branch, Hoa Duoc Viet Nam, Medochemie (Vien Dong) and Cuu Ton Pharmaceutical. All four were requested by the companies themselves; no violations are cited.
Under Official Letter 3826/QLD-KD, applications to import narcotic, psychotropic and precursor drugs and drug materials (procedures TT-38 and TT-39) can now be filed and processed online at https://dichvucong.dav.gov.vn.
The Ministry of Health has republished the procedures for granting, renewing, changing and withdrawing marketing authorisations for drugs and pharmaceutical starting materials under Circular 32/2026/TT-BYT. Decision 1983/QD-BYT, issued under the former Circular 12/2025/TT-BYT, is repealed.
The Ministry of Health places eight product groups at medium risk: infant and young-child formula products, plastic and rubber food-contact materials, bottled water and ready-to-use ice. The Circular took effect on 1 July 2026.
Four areas the portal covers.
Cited reference pages on Vietnamese drug registration, public tendering, pricing, and pharmacovigilance.
Search declared wholesale and winning tender prices, cross-referenced against the public DAV portals.
Structured search across DAV registrations, VSS tender results, VFA health-supplement certificates, and hospital tender notices.
Six categories — each with its own regulatory guides and reference data.
Medibase aggregates publicly available reference information from the Drug Administration of Vietnam (DAV), the Ministry of Health, Vietnam Social Security, and curated reference materials. Every regulatory citation links back to its official source.
The pages on Medibase are intended as a reference and do not replace professional medical advice or formal legal counsel. When using the information for registration, tendering, or commercial purposes, verify against the source text at the Official Gazette and the DAV portal.
